The effect of combined treatment with niacin and chromium (III) chloride on the different tissues of hyperlipemic rats

Drug and Chemical Toxicology

Volumn 29, Issue 4, 2006, Pages 363-377

  Atac, Inci A ^a   Peksel, Aysegul ^a   Yanardag, Refiye ^b   Sokmen, Bahar B ^b   Doger, Mutluhan M ^b   Bilen, Zeynep G ^b  

^a YILDIZ TECHNICAL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Chromium; Glutathione; Hyperlipemia; Lipid peroxidation; Niacin; Tissues

Indexed keywords

ALCOHOL; CATALASE; CHOLESTEROL; CHOLIC ACID; CHROMIUM CHLORIDE; GLUTATHIONE; LACTATE DEHYDROGENASE; LIPID; NICOTINIC ACID; SUNFLOWER OIL; WATER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HYPERLIPIDEMIA; LACTATE DEHYDROGENASE BLOOD LEVEL; LENS; LIPID BLOOD LEVEL; LIPID DIET; LIPID PEROXIDATION; NONHUMAN; RANDOMIZATION; RAT; SPLEEN; TONGUE;

ANIMALS; CATALASE; CHLORIDES; CHOLESTEROL; CHROMIUM COMPOUNDS; DIETARY FATS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; FEMALE; GLUTATHIONE; HYPERLIPIDEMIAS; L-LACTATE DEHYDROGENASE; LENS, CRYSTALLINE; LIPID PEROXIDATION; LIPIDS; NIACIN; RATS; SPLEEN; TONGUE;

ANIMALIA; HELIANTHUS;

EID: 33748646568     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.1080/01480540600820429     Document Type: Article

References (78)

1. Abraham, A. A., Brooks B. A., Eylath, U. (1992). The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent-diabetes. Metabolism 41:768-771.
2. Aebi, H. (1984). Catalase in vitro. Methods Enzymol. 105:121-126.
3. Anderson, R. A., Polansky, M. M., Bryden, N. A., Patterson, K. Y., Veillon, C., Glinsmann, W. H. (1983). Effects of chromium supplementation on urinary Cr excretion of human subjects and correlation of Cr excretion with selected clinical parameters. J. Nutr. 113:276-281.
4. Anderson, R. A., Polansky, M. M., Bryden, N. A., Canary, J. J. (1991). Supplemental chromium effects on glucose, insulin, glucagon, and urinary chromium losses in subjects consuming controlled low chromium diets. Am. J. Clin. Nutr. 54:909-916.
5. Anderson, R. A., Bryden, N. A., Polansky, M. M., Gautschi, K. (1996). Dietary chromium effects on tissue chromium concentrations and chromium absorption in rats. J. Trace Elements Exp. Med. 9:11-25.
6. Anderson, R. A., Bryden, N. A., Evock-Clover, C. M., Steele, N. C. (1997a). Beneficial effects of chromium on glucose and lipid variables in control and somatotropin-treated pigs are associated with increased tissue chromium and altered tissue copper, iron, and, zinc. J. Anim. Sci. 75:657-661.
7. Anderson, R. A., Bryden, N. A., Polansky, M. M. (1997b). Lack of toxicity of chromium chloride and chromium picolinate in rats. J. Am. Coll. Nutr. 16:273-279.
8. Ayar-Kayali, H., Özer, N., Tarhan, L. (2002). Intracellular superoxide dismutase, catalase and glutathione peroxidase activities and membrane lipid peroxide levels in Fusarium acuminatum upon environmental changes in a defined medium. Arch. Biochem. Biophys. 400:265-272.
9. Bagchi, D., Bagchi, M., Stohs, S. J., Das, D. K., Ray, S. D., Kuszynski, C. A., Joshi, S.S., Pruess, H.G. (2000). Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention. Toxicology 148:187-197.
10. Bagchi, D., Stohs, S. J., Downs, B. W., Bagchi M., Preuss, H. G. (2002). Cytotoxicity and oxidative mechanisms of different forms of chromium. Toxicology 180:5-22.
11. Bei, W., Peng, W., Ma, Y., Xu, A. (2005). Flavonoids from the leaves of Diospyros kaki reduce hydrogen peroxide-induced injury of NG108-15 cells. Life Sci. 76:1975-1988.
12. nd ed. New York: Grune and Stratton, eds. 2nd ed. New York, pp. 112-114.
13. Bhatnagar, D. (2002). Should pediatric patients with hyperlipidemia receive drug therapy? Pediatr. Drugs 4:223-230.
14. Blazovics, A., Feher, J., Feher, E., Petri, A. K., Petri, G. (1993). Liver protecting and lipid lowering effects of Sempervivum tectorum extract in the rat. Phytother. Res. 7:98-100.
15. Bolkent, S., Yanardag, R., Bolkent, S., Doger, M. M. (2004). Beneficial effects of combined treatment with niacin and chromium on the liver of hyperlipemic rats. Biol. Trace Elem. Res. 101:219-229.
16. Bourn, D. M., Gibson, R. S., Martinez, O. B., MacDonald, A. C. (1986). The effect of chromium supplementation on serum lipid levels in a selected sample of Canadian postmenopausal women. Biol. Trace Elem. Res. 9:197-205.
17. Brown, B. G., Bardsley, J., Poulin, D. et al. (1997). Moderate dose, three-drug therapy with niacin, lovastatin, and colestipol to reduce low density lipoprotein cholesterol <100 mg/dL in patients with hyperlipidemia and coronary artery disease. Am. J. Cardiol. 80:11-115.
18. Cohen, L., Morgan, J. (1988). Effectiveness of individualized long term therapy with niacin and probucol in reduction of serum cholesterol. J. Fam. Pract. 26:145-150.
19. Colquhoun, D. M. (2001). Nutraceuticals: vitamins and other nutrients in coronary heart disease. Curr. Opin Lipidol. 12:639-646.
20. Davidson, M. D. (2003). Niacin: A powerful adjunt to other lipid-lowering drugs in reducing plaque progression and acute coronary events. Curr. Atheroscler. Rep. 5:418-422.
21. Deepa P. R., Varalakshimi, P. (2004). Protective effects of certoparin sodium, a low molecular weight heparin derivative, in experimental atherosclerosis. Clin. Chim. Acta 339:105-115.
22. Dröge, W. (2002). Free radicals in the physiological control of cell function. Phys. Rev. 82:47-95.
23. Evans, P., Halliwel, B. (2001). Micronutrients: oxidant/antioxidant status. B. J. Nutr. 85:67-74.
24. Fang, Y., Yang, S., Wu, G. (2002). Free radicals, antioxidants, and nutrition. Nutrition 18:872-879.
25. Figge, H. L., Figge, J., Souney, P. M., Mutnick, A. H., Sacks, F. (1988). Nicotinic acid: a review of its clinical use in the treatment of lipid disorders. Pharmacotherapy 8:287-294.
26. Filling-Katz, M. R., Miller, S. P., Merrick, H. F., Travis, W. D. (1992). Clinical, pathologic, and biochemical features of a cholesterol lipidosis acompanied by hyperlipidemia and xanthomas. Neurology 42:1768-1774.
27. Fuentes, R., Usitalo, T., Puska, P., Tuomilehto, J., Nissinen, A. (2003). Blood cholesterol level and prevalence of hypercholesterolemia in developing countries: a review of population based studies carried out from 1979 to 2002. Eur. J. Cardiovasc. Prev. Rehabil. 10:411-419.
28. Galhardi, C. M., Diniz, Y. S., Faine, L. A., Rodrigues, H. G., Burneiko, R. C. M., Ribas B. O., Novelli, E. L. B. (2004). Toxicity of copper intake: lipid profile, oxidative stress and susceptibility to renal dysfunction. Food Chem. Toxicol. 42:2053-2060.
29. Ganji, S. H., Kamanna, S. V., Kashyap, M. L. (2003). Niacin and cholesterol: role in cardiovascular disease. J. Nutr. Biochem. 14:298-305
30. Goldberg, A. C. (1998). Clinical trial experience with extended-release niacin (Niaspan): dose-escalation study. Am. J. Cardiol. 82:35U-38U.
31. Goldberg, A., Alagona, P., Capuzzi, D. M. et al. (2000). Multiple-dose efficacy and safety of an extented-release form of niacin in the management of hyperlipidemia, Am. J. Cardiol. 85:1100-1105.
32. Guyton, J. R., Capuzzi, D. M. (1998). Treatment of hyperlipidemia with combined niacin-statin regimens. Am. J. Cardiol. 82:82-84.
33. Hintze, J. L. (1986). Number Cruncher Statistical System. Version 501. Kaysville. UT.
34. Hobbs, F. D., Erhardt, L. (2002). Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Fam. Pract. 19:596-604.
35. Hoyos, M., Guerrero, J. M., Perez-Cano, R., Olivan, J., Fabiani, F., Garcia-Pergenade, A., Osuna, C. (2000). Serum cholesterol and lipid peroxidation are decreased by melatonin in diet induced hypercholesterolemic rats. J. Pineal Res. 28:150-155.
36. Husain, K., Mejia, J., Lalla, J., Kazim, S. (2005). Dose response of alcohol-induced changes in BP, nitric oxide and antioxidants in rat plasma. Pharmacol. Res. 51:337-343.
37. Ikeda, K., Negishi, H., Yamori, Y. (2003). Antioxidant nutrients and hypoxia/ischemia brain injury in rodents. Toxicology 189:55-61.
38. Kegley, E. B., Spears, J. W., Eisemann, J. H. (1997). Performance and glucose metabolism in calves fed a chromium nicotinic acid complex or chromium chloride. J. Dairy Sci. 80:1744-1750.
39. Kelly, F. J. (1999). Glutathione: in defence of the lung. Food Chem. Toxicol. 37:963-966.
40. Kim, J., Dang, C. V. (2005). Multifaceted roles of glycolytic enzymes. Trends Biochem. Sci. 30:142-150.
41. Kimura, N., Fukuwatari, T., Sasaki R., Shibata, K. (2005). The necessity of niacin in rats fed on a high protein diet. Biosci. Biotechnol. Biochem. 69:273-279.
42. Knip, M., Douek, I.F., Moore, W. P. T., Gillmor, H. A., McLean, A. E. M., Bingley, P. J., Gale, E. A. M. (2000). Safety of high-dose nicotinamide: a review. Diabetologia 43:1337-1345.
43. Kumaraguruparan, R., Mohan, K. V. P. C., Abraham S. K., Nagini, S. (2005). Attenuation of N-methyl-N'-nitro-N-nitrosoguanidine induced genotoxicity and oxidative stress by tomato and garlic combination. Life Sci. 76:2247-2255.
44. Kurian, G. A., Philip S., Varghese T. (2005). Effect of aqueous extract of the Desmidium gangeticum DC root in the severity of myocardial infarction. J. Ethnopharmacol. 97:457-461.
45. Ledwozyw, J., Michalak, J., Stepien, A., Kadziolka, A. (1986). The relationship plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis. Clin. Chim. Acta 155:275-284.
46. Lefavi, R. G., Wilson, G. D., Keith, R. E., Anderson, R. A., Blessing, D. L., Hames C. G., McMillan, J. L. (1993). Lipid-lowering effect of a dietary chromium (III)-nicotinic acid complex in male athletes. Nutr. Res. 13:239-249.
47. Loeper, J., Goy, J., Rozensztajn, L., Bedu, O., Moisson, P. (1991). Lipid peroxidation and protective enzymes during myocardial infarction. Clin. Chim. Acta 196:119-126.
48. Lowry, H. O., Rosebrough, J. N., Farr, A. L., Randall, J. R. (1951). Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265-275.
49. Lundh, B. L., Nilsson, S. E. (1990). Lens changes in matched normals and hyperlipidemic patients treated with simvastatin for two years. Acta Opthalmol. 68:658-660.
50. Meyers, C. D., Carr, M. C., Park, S., Brunzell, J. D. (2003). Varying cost and free nicotinic acid content in over the counter niacin preparations for dyslipidemia. Ann Int. Med. 139:996-1002.
51. Mittal, G., Kaur, M., Soni, G. (2002). Impact of hypercholesterolemia on in vitro toxicity of N-nitrosodiethylamine: effect on lipidperoxidation of blood and tissue. Indian J. Exp. Biol. 40:1071-1073.
52. Morgan, J. M., Capuzzi, D. M, Guyton, J. R. (1998). A new extented-release niacin (niaspan): efficacy, tolerability, and safety in hypercholesterolemic patients. Am. J. Cardiol. 82:29-34.
53. Onat, A. (2001). Risk factors and cardiovascular disease in Turkey. Atherosclerosis 156:1-10.
54. Paolisso, G., Esposito, R., D'Alessio, M. A., Barbieri, M. (1999). Primary and secondary prevention of atherosclerosis: is there a role for antioxidants? Diabet. Metab. 25:298-306.
55. Pourahmad, J., Rabiei, M., Jokar, F., O'Brien, P. J. (2005). A comparison of hepatocyte cytotoxic mechanisms for chromate and arsenite. Toxicology 206:449-460.
56. Prasad, K., Kalra, J. (1989). Experimental atherosclerosis and oxygen free radicals. Angiology 40:835-843.
57. Preuss, H. G., Wallerstedt, D., Talpur, N., Tutuncuoglu, S. O., Echard, B.; Myers, A., Bui, M., Baghci, D. (2000). Effects of niacin-bound chromium and grape seed proanthocyanidin extract on the lipid profile of hypercholesterolemic subjects: a pilot study. J. Med. 31:227-246.
58. Rikans, L. L., Arata, D., Cederquist, D. C. (1965). Fatty livers produced in albino rats by excess niacin in high fat diets. II. Effects of choline supplements. J. Nutr. 85:107-112.
59. Roeback, J. R., Hla, K. M., Chambles, L. E., Fletcher, R. H. (1991). Effects of chromium supplementation on serum high density lipoprotein cholesterol levels in men taking beta-blockers. Ann. Intern. Med. 115:917-924.
60. Rosas, S., Szapary, P., Rader, D. J. (2003). Management of selected lipid abnormalities: hypertriglyceridemia, isolated low HDL-cholesterol, lipoprotein and lipid abnormalities in renal diseases and following solid organ transplantation. Cardiol. Clin. 21:377-392.
61. Rosengren, A., Stegmayr, B., Johansson, I., Huhtasaari, F., Wilhelmsen, L. (1999). Coronary risk factors, diet and vitamins as possible explanatory factors of the Swedish north-south gradient in coronary disease: a comparison between two Monica centres. J. Int. Med. 246:577-586.
62. Rosenson, R. S. (2003). Antiatherothrombotic effects of nicotinic acid. Atherosclerosis 171:87-96.
63. Ross, R. (1999). Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340:115-126.
64. Sakamoto, M., Yanagi, S., Kamiya, T. (1987). Inhibitory effects of niacin and its analogues on induction of ornithine decarboxylase activity by diethylnitrosamine in rat liver. Biochem. Pharm. 36:3015-3019.
65. Sanocka, D., Kurpisz, M. (2004). Reactive oxygen species and sperm cells. Reprod. Biol. Endocrinol. 2:1-7.
66. Shukla, R., Gupta S., Gambhir, J. K., Prabhu, K. M., Murthy, P.S. (2004). Antioxidant effect of aqueous extract of the bark of Ficus bengalensis in hypercholesterolaemic rabbits. J. Ethnopharmacol. 92:47-51.
67. Simonoff, M. (1984). Chromium deficiency and cardiovascular risk. Cardiovas. Res. 18:591-596.
68. Sullivan, D. R. (2002). Screening for cardiovascular disease with cholesterol. Clin. Chim. Acta 315:49-60.
69. Superko, H. R., Krauss, R. M. (1992). Differential effects of nicotinic acid in subjects with different LDL subclass patterns. Atherosclerosis 95:69-76.
70. Tavintharan, S., Kashyap, M. L. (2001). The benefits of niacin in atherosclerosis. Curr. Atheroscler. Rep. 3:74-72.
71. Tiwari, B. S., Belenghi, B., Levine, A. (2002). Oxidative stress increased respiration and generation of reactive oxygen species, resulting in ATP depletion, opening of mitochondrial permeability transition, and programmed cell death. Plant Physiol. 128:1271-1281.
72. Veerappan, R. M., Senthil, S., Rao, M. R., Ravikumar, R., Pugalendi, K. V. (2004). Redox status and lipid peroxidation in alcoholic hypertensive patients and alcoholic hypertensive patients with diabetes. Clin. Chim. Acta 340:207-212.
73. Vincent, J. B. (2004). Recent developments in the biochemistry of chromium (III). Biol. Trace Elem. Res. 99:1-16.
74. Witting, P., Pettersson, K., Östlund-Lindqvist, A. M., Westerlund, C., Wagberg, M., Stocker, R. (1999). Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbits. J. Clin. Invest. 104:213-220.
75. Wroblewski, F. (1957). Clinical significance of serum enzyme alterations associated with myocardial infarction. Am. Heart J. 54:219-224.
76. Yanardag, R., Peksel, A., Yesilyaprak, B., Doger, M. M., Arisan-Atac, I. (2005). Effects of a combination of niacin and chromium(III)-chloride on the skin and lungs of hyperlipemic rats. Biol. Trace Elem. Res. 103:249-260.
77. Zhao, R., Shen, G. X. (2005). Functional modulation of antioxidant enzymes in vascular endothelial cells by glycated LDL. Atherosclerosis 179:277-284.
78. Zima, T., Mestek, O., Tesar, V., Tesarova, P., Nemecek, K., Zak, A., Zeman, M. (1998). Chromium levels in patients with internal diseases. Biochem. Mol. Biol. Int. 46:365-374.